Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
J Bone Oncol
; 26: 100343, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33425673
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
J Bone Oncol
Year:
2021
Type:
Article
Affiliation country:
Canada